Squarepoint
LCTX icon

Squarepoint’s Lineage Cell Therapeutics LCTX Stock Holding History

Squarepoint’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$226K Buy
143,190
+78,081
+120% +$132K ﹤0.01% 3895
2025
Q4 		$109K Buy
+65,109
New +$113K ﹤0.01% 4027
2025
Q3 		– Sell
-511,107
Closed -$464K – 4740
2025
Q2 		$464K Buy
511,107
+153,335
+43% +$91K ﹤0.01% 3335
2025
Q1 		$162K Buy
357,772
+265,771
+289% +$156K ﹤0.01% 4089
2024
Q4 		$46.2K Buy
+92,001
New +$67.5K ﹤0.01% 4858
2024
Q3 		– Sell
-44,307
Closed -$44.2K – 4474
2024
Q2 		$44.2K Sell
44,307
-147,588
-77% -$163K ﹤0.01% 3916
2024
Q1 		$284K Buy
191,895
+18,597
+11% +$21.1K ﹤0.01% 3435
2023
Q4 		$189K Buy
173,298
+148,667
+604% +$163K ﹤0.01% 3619
2023
Q3 		$29.1K Sell
24,631
-7,294
-23% -$9.92K ﹤0.01% 3679
2023
Q2 		$45K Sell
31,925
-931
-3% -$1.29K ﹤0.01% 3449
2023
Q1 		$49.3K Buy
+32,856
New +$45.9K ﹤0.01% 3064

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return